Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. Academic Article uri icon

abstract

  • Idiopathic pulmonary fibrosis (IPF) is a progressive chronic disorder characterized by activation of fibroblasts and overproduction of extracellular matrix (ECM). Caveolin-1 (cav-1), a principal component of caveolae, has been implicated in the regulation of numerous signaling pathways and biological processes. We observed marked reduction of cav-1 expression in lung tissues and in primary pulmonary fibroblasts from IPF patients compared with controls. We also demonstrated that cav-1 markedly ameliorated bleomycin (BLM)-induced pulmonary fibrosis, as indicated by histological analysis, hydroxyproline content, and immunoblot analysis. Additionally, transforming growth factor beta1 (TGF-beta1), the well-known profibrotic cytokine, decreased cav-1 expression in human pulmonary fibroblasts. cav-1 was able to suppress TGF-beta1-induced ECM production in cultured fibroblasts through the regulation of the c-Jun N-terminal kinase (JNK) pathway. Interestingly, highly activated JNK was detected in IPF- and BLM-instilled lung tissue samples, which was dramatically suppressed by ad-cav-1 infection. Moreover, JNK1-null fibroblasts showed reduced smad signaling cascades, mimicking the effects of cav-1. This study indicates a pivotal role for cav-1 in ECM regulation and suggests a novel therapeutic target for patients with pulmonary fibrosis.

published proceedings

  • J Exp Med

altmetric score

  • 7

author list (cited authors)

  • Wang, X. M., Zhang, Y., Kim, H. P., Zhou, Z., Feghali-Bostwick, C. A., Liu, F., ... Choi, A

citation count

  • 319

complete list of authors

  • Wang, Xiao Mei||Zhang, Yingze||Kim, Hong Pyo||Zhou, Zhihong||Feghali-Bostwick, Carol A||Liu, Fang||Ifedigbo, Emeka||Xu, Xiaohui||Oury, Tim D||Kaminski, Naftali||Choi, Augustine MK

publication date

  • December 2006